Capacityscope
A business-development intelligence workspace for contract manufacturers and marketplace operators that joins public sponsor catalysts, inspection and facility evidence, hiring signals and authorized marketplace outcomes into source-linked six-to-twelve-month opportunity hypotheses without claiming available capacity, sponsor intent or regulatory fitness.
Manufacturing business-development teams can see trial milestones, inspection records, hiring activity and facility announcements, yet those signals live in different systems and do not by themselves prove that a sponsor will issue an RFQ or that a facility can accept work. The supplied research confirms a free competitor tracking more than 190 manufacturers, an enterprise forecasting product, a public European inspection database and a labor-market interface. It also confirms continuing pressure in biologics drug substance and aseptic fill-finish. Capacityscope creates an evidence graph linking a sponsor, program, catalyst, modality, timing range and required-capability hypothesis to candidate sites and marketplace workflow. Every match preserves source time, confidence, contradiction and expiry. Public data can prioritize research; it cannot assert confidential demand, free slots, quality status, commercial suitability or a contract award. Sponsor outreach, qualification, disclosure, RFQ receipt, facility response, technical review, quality review, marketplace introduction, proposal, award and actual manufacturing outcome remain separate. Marketplace outcome data can improve ranking only when authorized and de-identified under compatible definitions. The product never scrapes restricted sources, manufactures facility capacity, represents inspection status as approval or contacts a sponsor without human authorization.
A business-development head at a contract manufacturer or the operator of a contract-manufacturing marketplace seeking earlier, explainable sponsor-opportunity discovery.
Teams want early proprietary demand intelligence from signals that remain public, incomplete and non-probative.
Public catalyst data and confirmed biologics and fill-finish pressure support a current window.
The gap is clearer than the historical reason it remained unbuilt.
A clear business-development buyer, confirmed demand pressure, public catalyst and inspection sources, two verified interfaces and a marketplace learning loop support the concept.
Two referenced capabilities remain unverified, the barrier to entry and incumbent conflict are weak, public signals can be stale, and neither sponsor demand nor site availability can be inferred directly.
Discussion
No comments yet — be the first to weigh in.